靶点- |
作用机制- |
|
|
|
非在研适应症- |
最高研发阶段临床前 |
首次获批国家/地区- |
首次获批日期- |
WNTR-VZV-001: A Phase Ib, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Tolerability of Solexan™ (arginine undecylenate) when Administered Topically to Acute Varicella Zoster Virus (Shingles) Lesions.
100 项与 Wintermute Biomedical LLC 相关的临床结果
0 项与 Wintermute Biomedical LLC 相关的专利(医药)
100 项与 Wintermute Biomedical LLC 相关的药物交易
100 项与 Wintermute Biomedical LLC 相关的转化医学